Biological Intellectual Property Protection Act of 2025

Key Points

• Would require export licenses for sharing digital files of human-designed synthetic DNA or RNA with certain foreign groups.
• Targets “foreign entities of concern,” including governments and companies tied to countries the U.S. flags as high-risk.
• Covers exports, reexports, and even transfers inside another country when the recipient is a covered foreign entity.
• Sets a 1-year deadline for the Commerce Department to put the license requirement in place.
• Could add paperwork and delays for biotech researchers and companies when collaborating with some overseas partners.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.